CLINICAL TRIALS PROFILE FOR DEXMETHYLPHENIDATE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for DEXMETHYLPHENIDATE HYDROCHLORIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00047476 ↗ | D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients | Completed | Celgene Corporation | Phase 2 | 2002-06-01 | To evaluate the efficacy of dexmethylphenidate (d-MPH) in the treatment of chemotherapy-related fatigue in adult cancer subjects. |
| NCT00141050 ↗ | Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD | Completed | Novartis | Phase 3 | 2005-05-01 | The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD. |
| NCT00141063 ↗ | Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD | Completed | Novartis | Phase 3 | 2005-06-01 | The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD. |
| NCT00301236 ↗ | Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder | Completed | Novartis | Phase 3 | 2006-02-01 | The purpose of this study is to determine which dosages of dexmethylphenidate HCl extended-release capsules may represent effective treatment for ADHD in children 6-12 years of age. |
| NCT00361387 ↗ | Use of Focalin for Fatigue in Sarcoidosis | Completed | University of Cincinnati | Phase 4 | 2006-06-01 | Patients diagnosed with chronic sarcoidosis with fatigue for more than 6 months. Sarcoidosis and its treatment can greatly affect your quality of life. Many patients suffer from fatigue (feeling tired), lack of focus and concentration, in ability to organize their daily activities, and memory loss. These commonly reported symptoms often get in the way of everyday life. |
| NCT00393042 ↗ | Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR | Completed | Novartis | Phase 3 | 2006-01-01 | The purpose of this study is to evaluate how children and adolescents with Attention Deficit/ Hyperactivity Disorder (ADHD) respond to treatment with three differing doses of stimulant medications used to treat ADHD, Adderall XR® and Focalin XR®. Another purpose of the study is to evaluate if there are differences in sleep and other side effects, such as changes in mood or loss of appetite, which can occur with stimulant medications. A third purpose is to determine if there are differences in the characteristics of individuals who respond better to either of the medications. This research is being done because the investigators do not know if one of these two commonly used treatments is better tolerated than the other. Children and adolescents with ADHD often have a hard time sitting still, playing quietly, finishing things they start, paying attention, waiting their turn, and not distracting others. These medications improve these symptoms, but sometimes affect sleep, appetite, or mood. It is hypothesized that at effective and frequently prescribed doses, Adderall will be associated with insomnia, more stimulant side effects, and decreased tolerability during an acute trial relative to Focalin. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DEXMETHYLPHENIDATE HYDROCHLORIDE
Condition Name
Clinical Trial Locations for DEXMETHYLPHENIDATE HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for DEXMETHYLPHENIDATE HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for DEXMETHYLPHENIDATE HYDROCHLORIDE
Sponsor Name
